RESEARCH AND DEVELOPMENT

We believe that constant research and innovation is crucial for the patient’s health care.






Together with our network of international partners, we consider it essential to fully investigate cannabis-based medicine in order to understand their mode of action. Based on this research, we are constantly improving our product-portfolio and developing new preparations made from the cannabis plant. We have the ambition to provide patients, with the best possible cannabinoid-treatment and provide physicians and pharmacists with education about the cannabis-plant.


Our International Network of R&D partners



Connect 4


Connect 4 is founding partner of CanPharma and is extending our expertise, when it comes to questions regarding market access for pharmaceuticals and medical devices. Among others Connect 4 has years of experiences in the fields of regulatory affairs, market intelligence, market entry and market penetration. Together with the Connect 4 team, we are expanding the variety of products on the market with new, great cannabis-based pharmaceuticals.





Do you have any questions?

Logo Can Pharma SVG

CanPharma has a pharmaceutical wholesale permission according to §52a of the German Medicines Act, as well as a license to handle narcotics in the meaning of §3 of the German narcotics legislation. Furthermore, CanPharma has a GDP-certified quality assurance system.

MEMBER OF

HEADQUARTERS

CanPharma GmbH
Wiesbadener Str. 29
16515 Oranienburg, Germany

REPRESENTATIVE OFFICES

Berlin
Rosenthaler Str. 34
10178 Berlin
Germany

Barcelona
Gran de Gràcia 15, 1-1
08012 Barcelona
Spain